Yazji Salim 4
4 · Oncternal Therapeutics, Inc. · Filed Apr 14, 2023
Insider Transaction Report
Form 4
Yazji Salim
Chief Medical Officer
Transactions
- Purchase
Common Stock
2023-04-13$0.28/sh+10,000$2,850→ 159,676 total - Purchase
Common Stock
2023-04-14$0.30/sh+5,000$1,500→ 164,676 total - Purchase
Common Stock
2023-04-12$0.28/sh+10,000$2,850→ 149,676 total